Advertisement

Characteristics of Specific Radiopharmaceuticals

  • Gopal B. Saha

Abstract

In Chapter 6 the general principles of labeling methods, particularly iodination and 99mTc-labeling, have been discussed, and kit preparation for formulation of 99mTc-radiopharmaceuticals has been described. In this chapter the practical aspects of preparation, labeling yield, stability, storage conditions, and other characteristics of radiopharmaceuticals most commonly used in nuclear medicine will be discussed.

Keywords

Human Serum Albumin Label Efficiency Stannous Chloride Label Yield Albumin Microsphere 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Suggested Reading

  1. Callahan RJ, Froelich JW, McKusick KA, et al. A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication. J Nucl Med. 1982; 23:315.PubMedGoogle Scholar
  2. Dewanjee MK. The chemistry of 99mTc-labeled radiopharmaceuticals. Semin Nucl Med. 1990; XX : 5.Google Scholar
  3. Ege GN, Warbick A. Lymphoscintigraphy: a comparison of Tc-99m antimony sulfide and Tc-99m stannous phytate. Br J Radiol. 1979; 53 : 124.CrossRefGoogle Scholar
  4. Fritzberg AR, Kasina S, Eshima D, et al. Synthesis and biological evaluation of technetium-99m MAG3 as hippuran replacement. J Nucl Med. 1986; 27 :11.Google Scholar
  5. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of NCA 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986; 27 : 235.PubMedGoogle Scholar
  6. Hnatowich DJ. Recent developments in the radiolabeling of antibodies with iodine, indium and technetium. Semin Nucl Med. 1990; XX : 80.Google Scholar
  7. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256 : 495.PubMedCrossRefGoogle Scholar
  8. Loberg MD, Cooper M, Harvey E, et al. Development of new radiopharmaceutical based on N-substitution of iminodiacetic acid. J Nucl Med. 1976; 17 : 633.PubMedGoogle Scholar
  9. Nunn AD. Radiopharmaceutical for imaging myocardial perfusion. Semin Nucl Med. 1990; XX: 111.Google Scholar
  10. Package inserts of various kits available from commercial suppliers.Google Scholar
  11. Peters AM, Danpure HJ, Osman S, et al. Clinical experience with 99mTchexamethyl propylene amine oxime for labeling leukocytes and imaging inflammation. Lancet. 1986; 2 : 946.PubMedCrossRefGoogle Scholar
  12. Smith TD, Richards P. A simple kit for the preparation of Tc-99m red blood cells. J Nucl Med. 1976; 17 : 126.PubMedGoogle Scholar
  13. Sodd VJ, Allen DR, Hoagland DR, et al., eds. Radiopharmaceuticals II. New York: Society of Nuclear Medicine; 1979.Google Scholar
  14. Srivastava SC, Straub RF. Blood cell labeling with 99mTc: progress and perspectives. Semin Nucl Med. 1990; XX : 41.Google Scholar
  15. ten Berge RJM, Natarajan AT, Hardenman MR, et al. Labeling with indium-111 has detrimental effects on human lymphocytes. J Nucl Med. 1983; 24 : 615.PubMedGoogle Scholar
  16. Thakur ML, Coleman RE, Welch MJ. Indium-111-labeled leukocytes for the localization of abscesses: preparation, analysis, tissue distribution and comparison with gallium-67 citrate in dogs. J Lab Clin Med. 1977; 82 : 217.Google Scholar
  17. Troutner DR, Volkert WA, Hoffman TJ, et al. A neutral lipophilic complex of Tc-99m with a multidentate amine oxime. Int J Appl Rad Isot. 1984; 35 : 467.CrossRefGoogle Scholar
  18. U.S. Pharmacopeia XXII. United States Pharmacopeial Convention, Rockville, Md; 1990.Google Scholar
  19. Walovitch RC, Hill TC, Garrity ST, et al. Characterization of technetium-99mL,L-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m ECD in nonhuman primates. J Nucl Med. 1989; 30 : 1892.PubMedGoogle Scholar
  20. Welch MJ, ed. Radiopharmaceuticals and other compounds labelled with shortlived radionuclides. New York: Pergamon Press; 1977.Google Scholar
  21. Zuckier LS, Rodriguez LD, Scharff MD. Immunologic and pharmacologic concepts of monoclonal antibodies. Semin Nucl Med. 1990; XX: 166.Google Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Gopal B. Saha
    • 1
  1. 1.Department of Nuclear MedicineThe Cleveland Clinic FoundationClevelandUSA

Personalised recommendations